Autophagy and liver ischemia-reperfusion injury

Autophagy: Principles, Regulation and Roles in Disease

Volumn , Issue , 2012, Pages 297-328

  Cursio, Raffaele ^a,b   Colosetti, Pascal ^b   Auberger, Patrick ^b   Gugenheim, Jean ^a,b  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^b INSERM   (France)

Author keywords

Apoptosis; Autophagy; Ischemia; Ischemic preconditioning; Liver; Necrosis; Reperfusion injury

Indexed keywords

EID: 84892056670     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (198)

1. Cursio, R; Gugenheim, J; Ricci, JE; Crenesse, D; Rostagno, P; Maulon, L; Saint-Paul, M-C; Ferrua, B; Gugenheim, J. A caspase inhibitor fully protects rats against lethal normothermic liver ischemia by inhibition of liver apoptosis. FASEB J. 1999;13:253-261.
2. Cursio, R. Liver ischemia-reperfusion injury in the rat: role of nonparenchymal liver cells. Postdoctoral thesis on liver transplantation. University of Paris XI, 14 Nov 2002, Paris, France.
3. Jaeschke, H; Lemasters, JJ. Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. Gastroenterology. 2003;125:1246-57.
4. Cursio, R; Filippa, N; Miele, C; Van Obberghen, E; Gugenheim, J. Involvement of protein kinase B nad mitogen-activated protein kinases in experimental normothermic liver ischaemia-reperfusion injury. Br. J. Surg. 2006;93:752-61.
5. Cursio, R. Caspase inhibition in liver transplantation: from basic research to clinical studies. HPB. 2010;12:1-2.
6. Gao, W; Bentley, RC; Madden, JF; Clavien, PA. Apoptosis of sinusoidal endothelial cells is a critical mechanism of preservation injury in rat liver transplantation. Hepatology. 1998;27:1652-60.
7. Cursio, R; Colosetti, P; Saint Paul M-C; Pagnotta, S; Gounon, P; Iannelli, A; Auberger, P; Gugenheim, J. Induction of different types of cell death after normothermic liver ischemia-reperfusion. Transplant. Proc. 2010;42:3977-80.
8. Cardinal, J; Pan, P; Tsung, A. Protective role of cisplatin in ischemic liver injury through induction of autophagy. Autophagy. 2009;8:1211-2.
9. Gotoh, K; Lu, Z; Morita, M; Shibata, M; Koike, M; Waguri, S; Dono, K; Doki, Y; Kominami, E; Sugioka, A; Monden, M; Uchiyama, Y. Participation of autophagy in the initiation of graft dysfunction after rat liver transplantation. Autophagy. 2009;5:351-60.
10. Minor, T; Stegemann, J; Hirner, A; Koetting, M. Impaired autophagy clearance after cold preservation of fatty livers correlates with tissue necrosis upon reperfusion and is reversed by hypothermic reconditioning. Liver Transplant. 2009;15:798-805.
11. Shin, T; Kuboki, S; Huber, N; Eismann, T; Galloway, E; Schuster, R; Blanchard, J; Pritts, TA; Lentsch, AB. Activation of peroxisome proliferator-activated receptorgamma during hepatic ischemia is age-dependent. J. Surg. Res. 2008;147:200-5.
12. Kim, JS; Nitta, T; Mohuczy, D; O'Malley, KA; Moldawer, LL; Dunn, WA; Behrns, KE. Impaired autophagy: A mechanism of mitochondrial dysfunction in anoxic rat hepatocytes. Hepatology. 2008;47:1725-36.
13. Lu, Z; Dono, K; Gotoh, H; Shibata, M; Koike, M; Marubashi, S; Miyamoto, A; Takeda, Y; Nagano, H; Umeshita, K, Uchiyama, Y; Monden, M. Participation of autophagy in the degeneration process of rat hepatocytes after transplantation following prolonged cold preservation. Arch. Histol. Cytol. 2005;68:71-80.
14. Degli Esposti, D; Sebagh, M; Pham, P; Reffas, M; Poüs, C; Brenner, C; Azoulay, D; Lemoine, A. Ischemic preconditioning induces autophagy and limits necrosis in human recipients of fatty liver grafts, decreasing the incidence of rejection episodes. Cell Death Dis. 2011 Jan 13;2:e111.
15. Domart, MC; Esposti, DD; Sebagh, M; Olaya, N; Harper, F; Pierron, G; Franc, B; Tanabe, KK; Debuire, B; Azoulay, D; Brenner, C; Lemoine, A. Concurrent induction of necrosis, apoptosis, and autophagy in ischemic preconditioned human livers formerly treated by chemotherapy. J. Hepatol. 2009;51:881-9.
16. Deter, RL; De Duve, C. Influence of glucagon, an inducer of cellular autophagy, on some physical properties of rat liver lysosomes. J. Cell Biol. 1967;33:437-449.
17. Deter, RL; Baudhuin, P; De Duve, C. Participation of lysosomes in cellular autophagy induced in rat liver by glucagons. J. Cell Biol. 1967;35:C11-16.
18. Omodei Zorini, A. Considerations on primary carcinomatous caverns of the lung. Possibility of the intervention of a phenomenon of "autophagy of the neoplastic cells", Lotta Tuberc. 1965;35:946-c68.
19. Baudhuin, P. Lysosomes and cellular autophagy, Brux Med. 1966;46:1059-1070.
20. White, E. Autophagic cell death unraveled: Pharmacological inhibition of apoptosis and autophagy enables necrosis. Autophagy. 2008;4:399-401.
21. Ratou, PE; Mansouri, A; Lebrec, D; Durand, F; Valla, D; Moreau, R. Autophagy in liver diseases. J. Hepatol. 2010;53:1123-34.
22. Clavien, PA; Harvey, PR; Strasberg, SM. Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies. Transplantation. 1992;53:957-78.
23. McKeown, CM; Edwards, V; Phillips, MJ; Harvey, PR; Petrunka, CN; Strasberg, SM. Sinusoidal lining cell damage: the critical injury in cold preservation of liver allografts in the rat. Transplantation. 1988;46:178-91.
24. Farmer, DG; Amersi, F; Kupiec-Weglinski, JW. Current status of ischemia and reperfusion injury in the liver. Transplant. Rev. 2000;14:106-126.
25. Busuttil, R. Liver ischemia and reperfusion injury. Br. J. Surg. 2007;94:787-8.
26. Glanemann, M; Langrehr, JM; Stange, BJ; Neumann, U; Settmacher, U; Steinmüller, T; Neuhaus, P. Clinical implications of hepatic preservation injury after adult liver transplantation. Am. J. Transplant. 2003;3:1003-9.
27. Mueller, AR; Platz, KP; Haak, M; Undi, H; Müller, C; Köttgen, E; Weidemann, H; Neuhaus, P. The release of cytokines, adhesion molecules, and extracellular matrix parameters during and after reperfusion in human liver transplantation. Transplantation. 1996;62:1118-26.
28. Halloran, PF. Call for revolution: a new approach to describing allograft deterioration. Am. J. Transplant. 2002;2:195-200.
29. Gourishankar, S, Halloran, PF. Late deterioration of organ transplants: a problem in injury and homeostasis. Curr. Opin. Immunol. 2002;14:576-83.
30. de Rougemont, O; Lehmann, K; Clavien, PA. Preconditioning, organ preservation, and postconditioning to prevent ischemia-reperfusion injury to the liver. Liver Transpl. 2009;15:1172-82.
31. Huguet, C; Nordlinger, B; Bloch, P; Conard, J. Tolerance of the human liver to prolonged normothermic ischemia. A biological study of 20 patients submitted to extensive hepatectomy. Arch. Surg. 1978;113:1448-51.
32. Huguet, C; Gavelli, A; Chieco, PA; Bona, S; Harb, J; Joseph, JM; Jobard, J; Gramaglia, M; Lasserre, M. Liver ischemia for hepatic resection: where is the limit? Surgery. 1992;111:251-9.
33. Huguet, C; Gavelli, A; Bona, S. Hepatic resection with ischemia of the liver exceeding one hour. J. Am. Coll. Surg. 1994;178:454-8.
34. Belghiti, J; Hiramatsu, K; Benoist, S; Massault, P; Sauvanet, A; Farges, O. Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J. Am. Coll. Surg. 2000;191:38-46.
35. Sherlock, S. Acute fatty liver of pregnancy and the microvesicular fat diseases. Gut. 1983;24:265-9.
36. Bellentani, S; Saccoccio, G; Masutti, F; Crocě, LS; Brandi, G; Sasso, F; Cristanini, G; Tiribelli, C. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann. Intern. Med. 2000;132:112-7.
37. Silverman, JF; O'Brien, KF; Long, S; Leggett, N; Khazanie, PG; Pories, WJ; Norris, HT; Caro, JF. Liver pathology in morbidly obese patients with and without diabetes. Am. J. Gastroenterol. 1990;85:1349-55.
38. Jaeschke, H. Mechanisms of reperfusion injury after warm ischemia of the liver. J Hepatobiliary Pancreat. Surg. 1998;5:402-8.
39. Pannen, BH; Al-Adili, F; Bauer, M; Clemens, MG; Geiger, KK. Role of endothelins and nitric oxide in hepatic reperfusion injury in the rat. Hepatology. 1998;27:755-64.
40. Sun, CK; Zhang, XY; Zimmermann, A; Davis, G; Wheatley, AM. Effect of ischemia-reperfusion injury on the microcirculation of the steatotic liver of the Zucker rat. Transplantation. 2001;72:1625-31.
41. Clavien, PA; Selzner, M; Rüdiger, HA; Graf, R; Kadry, Z; Rousson, V; Jochum, W. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann. Surg. 2003;238:843-50.
42. Bernau, J; Rueff, B; Benhamou, J-P. Fulminant and subfulminant liver failure: definitions and causes. Semin. Liv. Dis. 1986;6:97-106.
43. Velmahos, GC; Toutouzas, K; Radin, R; Chan, L; Rhee, P; Tillou, A; Demetriades, D. High success with nonoperative management of blunt hepatic trauma: the liver is a sturdy organ. Arch. Surg. 2003;138:475-80.
44. Saltzherr, TP; van der Vlies, CH; van Lienden, KP; Beenen, LF; Ponsen, KJ; van Gulik, TM; Goslings, JC. Improved outcomes in the non-operative management of liver injuries. HPB. 2011;13:350-5.
45. Kozar, RA; McNutt, MK. Management of adult blunt hepatic trauma. Curr. Opin. Crit. Care. 2010 Sep 9. [Epub ahead of print]
46. Piper, GL; Peitzman, AB. Current management of hepatic trauma. Surg. Clin. North Am. 2010;90:775-85.
47. Polanco; P; Leon, S; Pineda, J; Puyana, JC; Ochoa, JB; Alarcon, L; Harbrecht, BG; Geller, D; Peitzman, AB. Hepatic resection in the management of complex injury to the liver. J. Trauma. 2008;65:1264-9.
48. Patcher, HL; Spencer, FC; Hofstetter, SR; Liang, HG; Coppa, GF. Significant trends in the treatment of hepatic trauma. Experience with 411 injuries. Ann. Surg. 1992;5:492-500.
49. Bismuth, H; Castaing, D; Garden, OJ. Major hepatic resection under total vascular exclusion. Ann. Surg. 1989;210:13-9.
50. Asensio, JA; Roldán, G; Petrone, P; Rojo, E; Tillou, A; Kuncir, E; Demetriades, D; Velmahos, G; Murray, J; Shoemaker, WC; Berne, TV; Chan, L. Operative management and outcomes in 103 AAST-OIS grades IV and V complex hepatic injuries: trauma surgeons still need to operate, but angioembolization helps. J. Trauma. 2003;54:647-53.
51. Caruso, DM; Battistella, FD; Owings, JT; Lee, SL; Samaco, RC. Perihepatic packing of major liver injuries: complications and mortality. Arch. Surg. 1999;134:958-62.
52. Ringe, B; Pichlmayr, R; Ziegler, H; Grosse; H; Kuse, E; Oldhafer, K; Bornscheuer, A; Gubernatis, G. Management of severe hepatic trauma by two-stage total hepatectomy and subsequent liver transplantation. Surgery. 1991;109:792-5.
53. Tucker, ON; Marriott, P; Rela, M; Heaton, N. Emergency liver transplantation following severe liver trauma. Liver Transpl. 2008;14:1204-10.
54. Patel, MS; Malinoski, DJ; Nguyen, XM; Hoyt, DB. The impact of select chronic diseases on outcomes after trauma: a study from the National Trauma Data Bank. J. Am. Coll. Surg. 2011;212:96-104.
55. Lin; BC; Fang, JF; Wong, YC; Hwang, TL; Hsu, YP. Management of cirrhotic patients with blunt abdominal trauma: Analysis of risk factor of postoperative death with the Model for End-Stage Liver Disease score. Injury. 2011 Apr 19. [Epub ahead of print]
56. Hassoun, HT; Kone, BC; Mercer, DW; Moody, FG; Weisbrodt, NW; Moore, FA. Postinjury multiple organ failure: the role of the gut. Shock. 2001;15:1-10.
57. Harbrecht, BG; Doyle, HR; Clancy, KD; Townsend, RN; Billiar, TR; Peitzman, AB. The impact of liver dysfunction on outcome in patients with multiple injuries. Am. Surg. 2001;67:122-6.
58. Jaeschke, H; Farhood, A. Kupffer cell activation after no-flow ischemia versus hemorrhagic shock. Free Radic Biol. Med. 2002;33:210-9.
59. Champion, HR; Jones, RT; Trump, BF; Decker, R; Wilson, S; Stega, M; Nolan, J; Crowley, RA; Gill, W. Post-traumatic hepatic dysfunction as a major etiology in posttraumatic jaundice. J. Trauma. 1976;16:650-7.
60. Chang, CG; Van Way, CW; Dhar, A; Helling, T; Hahn, Y. The use of insulin and glucose during resuscitation from hemorrhagic shock increases hepatic ATP. J. Surg. Res. 2000;92:171-6.
61. Shires, GT; Browder, LK; Steljes, TP; Williams, SJ; Browder, TD; Barber, AE. The effect of shock resuscitation fluids on apoptosis. Am. J. Surg. 2005;189:85-91.
62. Szabó, C; Billiar, TR. Novel roles of nitric oxide in hemorrhagic shock. Shock. 1999;12:1-9.
63. Shimizu, T; Tani, T; Hanasawa, K; Endo, Y; Kodama, M. The role of bacterial translocation on neutrophil activation during hemorrhagic shock in rats. Shock. 2001;16:59-63.
64. El-Wahsh, M; Seifalian, AM; Fuller, BJ; Rolles, K; Davidson, BR. Induction of adhesion molecule expression in liver ischaemia-reperfusion injury is associated with impaired hepatic parenchymal microcirculation. Br. J. Surg. 2004;91:1034-9.
65. Brundage, SI; Schreiber, MA; Holcomb, JB; Zautke, N; Mastrangelo, MA; Xq, X; Macaitis, J; Tweardy, DJ. Amplification of the proinflammatory transcription factor cascade increases with severity of uncontrolled hemorrhage in swine. J. Surg. Res. 2003;113:74-80.
66. Wang, P; Ayala, A; Ba, ZF; Zhou, M; Perrin, MM; Chaudry, IH. Tumor necrosis factor-alpha produces hepatocellular dysfunction despite normal cardiac output and hepatic microcirculation. Am. J. Physiol. 1993;265:G126-32.
67. Wang, P; Ba, ZF; Chaudry, IH. Endothelial cell dysfunction occurs very early following trauma-hemorrhage and persists despite fluid resuscitation. Am. J. Physiol. 1993;265:H973-9.
68. Yamakawa, Y; Takano, M; Patel, M; Tien, N; Takada, T; Bulkley, GB. Interaction of platelet activating factor, reactive oxygen species generated by xanthine oxidase, and leukocytes in the generation of hepatic injury after shock/resuscitation. Ann. Surg. 2000;231:387-98.
69. Okano, N; Miyoshi, S; Owada, R; Fujita, N; Kadoi, Y; Saito, S; Goto, F; Morita, T. Impairment of hepatosplanchnic oxygenation and increase of serum hyaluronate during normothermic and mild hypothermic cardiopulmonary bypass. Anesth. Analg. 2002;95:278-86.
70. Glantzounis, GK; Tselepis, AD; Tambaki, AP; Trikalinos, TA; Manataki, AD; Galaris, DA; Tsimoyiannis, EC; Kappas, AM. Laparoscopic surgery-induced changes in oxidative stress markers in human plasma. Surg. Endosc. 2001;15:1315-9.
71. Glantzounis, GK; Tsimaris, I; Tselepis, AD; Thomas, C; Galaris, DA; Tsimoyiannis, EC. Alterations in plasma oxidative stress markers after laparoscopic operations of the upper and lower abdomen. Angiology. 2005;56:459-65.
72. Rezende-Neto, JB; Moore, EE; Masuno, T; Moore, PK; Johnson, JL; Sheppard, FR; Cunha-Melo, JR; Silliman, CC. The abdominal compartment syndrome as a second insult during systemic neutrophil priming provokes multiple organ injury. Shock. 2003;20:303-8.
73. Jaeschke, H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am. J. Physiol. Gastrointest. Liver Physiol. 2003;284:G15-26.
74. Rappaport, AM; Hiraki, GY. The anatomical pattern of lesions in the liver. Acta Anat. 1958;32:126-40.
75. Jungermann, K; Kietzmann, T. Zonation of parenchymal and nonparenchymal metabolism in liver. Annu. Rev. Nutr. 1996;16:179-203.
76. Trump, BF; Goldblatt, PJ; Stowell, RE. Studies of necrosis in vitro of mouse hepatic parenchymal cells. Ultrastructural alterations in endoplasmic reticulum, Golgi apparatus, plasma membrane, and lipid droplets. Lab. Invest. 1965;14:2000-28.
77. Dogan, S, Aslan, M. Hepatic ischemia-reperfusion injury and therapeutic strategies to alleviate cellular damage. Hepatol. Res. 2011;41:103-17.
78. Marotto, ME; Thurman, RG; Lemasters, JJ. Early midzonal cell death during low-flow hypoxia in the isolated, perfused rat liver: protection by allopurinol. Hepatology. 1988;8:585-90.
79. Sasse, D; Spornitz, UM; Maly, IP. Liver architecture. Enzyme. 1992;46:8-32.
80. Jungermann, K; Kietzmann, T. Oxygen: modulator of metabolic zonation and disease of the liver. Hepatology. 2000;31:255-60.
81. Cherid, A; Cherid, N; Chamlian, V; Hardwigsen, J; Nouhou, H; Dodero, F; Benkoel, L; Le Treut, YP; Chamlian, A. Evaluation of glycogen loss in human liver transplants. Histochemical zonation of glycogen loss in cold ischemia and reperfusion. Cell Mol. Biol. 2003;49:50914.
82. Abu-Amara, M; Yang, SY; Quaglia, A; Rowley, P; Fuller, B; Seifalian, A; Davidson, B. Role of endothelial nitric oxide synthase in remote ischemic preconditioning of the mouse liver. Liver Transpl. 2011;17:610-9.
83. Jaeschke, H. Redox considerations in hepatic injury and inflammation. Antioxid. Redox Signal. 2002;4:699-700.
84. Mavier, P; Guigui, B; Preaux, AM; Rosenbaum, J; Lescs, MC; Zafrani, ES; Dhumeaux, D. In vitro toxicity of hydrogen peroxide against normal vs. tumor rat hepatocytes: role of catalase and of the glutathione redox cycle. Hepatology. 1988;8:1673-8.
85. Li, XK; Matin, AF; Suzuki, H; Uno, T; Yamaguchi, T; Harada, Y. Effect of protease inhibitor on ischemia/reperfusion injury of the rat liver. Transplantation. 1993;56:1331-6.
86. Cursio, R; Mari, B; Louis, K; Rostagno, P; Saint-Paul, M-C; Giudicelli, J; Bottero, V; Anglard, P; Yiotakis, A; Dive, V; Gugenheim, J; Auberger, P. Rat liver injury after normothermic ischemia is prevented by a phosphinic matrix metalloproteinase inhibitor. FASEB J. (November 14, 2001) 10.1096/fj.01-0279fje
87. Vollmar, B; Glasz, J; Leiderer, R; Post, S; Menger, MD. Hepatic microcirculatory perfusion failure is a determinant of liver dysfunction in warm ischemia-reperfusion. Am. J. Pathol. 1994;145:1421-31.
88. Lemasters, JJ. V. Necrapoptosis and the mitochondrial permeability transition: shared pathways to necrosis and apoptosis. Am. J. Physiol. 1999;276:G1-6.
89. Codogno, P; Meijer, AJ. Autophagy and signaling: their role in cell survival and cell death. Cell Death Differ. 2005;12:1509-18.
90. Loud, AV. A quantitative stereological description of the ultrastructure of normal rat liver parenchymal cells. J. Cell Biol. 1968;37:27-46.
91. Komatsu, M; Waguri, S; Ueno, T; Iwata, J; Murata, S; Tanida, I; Ezaki, J; Mizushima, N; Ohsumi, Y; Uchiyama, Y; Kominami, E; Tanaka, K; Chiba, T. Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J. Cell Biol. 2005;169:425-34.
92. Yin, XM; Ding, WX; Gao, W. Autophagy in the liver. Hepatology. 2008;47:1773-85.
93. Levine, B; Yuan, J. Autophagy in cell death: an innocent convict? J. Clin. Invest. 2005;115:2679-88.
94. Huang, J; Klionsky, DJ. Autophagy and human disease. Cell Cycle. 2007;6:1837-49.
95. Czaja, MJ. Two types of autophagy are better than one during hepatocyte oxidative stress. Autophagy. 2011;7:96-7.
96. Chen, Y; Azad, MB; Gibson, SB. Methods for detecting autophagy and determining autophagy-induced cell death. Can. J. Physiol. Pharmacol. 2010;88:285-95.
97. Maiuri, MC; Zalckvar, E; Kimchi, A; Kroemer, G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat. Rev. Mol. Cell Biol. 2007;8:741-52.
98. Platini, F; Pérez-Tomás, R; Ambrosio, S; Tessitore, L. Understanding autophagy in cell death control. Curr. Pharm. Des. 2010;16:101-13.
99. Belzer, FO, Southard JH. Principles of solid-organ preservation by cold storage. Transplantation. 1988;45:673-6.
100. Jassem, W; Fuggle, SV; Rela, M; Koo, DD; Heaton, ND. The role of mitochondria in ischemia/reperfusion injury. Transplantation. 2002;73:493-9.
101. Chen, Y; Azad, M; Gibson, SB. Superoxide is the major reactive oxygen species regulating autophagy. Cell Death Differ. 2009;16:1040-52.
102. Huang, J; Canadien, V; Lam, GY; Steinberg, BE; Dinauer, MC; Magalhaes, MA; Glogauer, M; Grinstein, S; Brumell, JH. Activation of antibacterial autophagy by NADPH oxidases. Proc. Natl. Acad. Sci. U. S. A. 2009;106:6226-31.
103. Scherz-Shouval, R; Elazar, Z. ROS, mitochondria and the regulation of autophagy. Trends Cell Biol. 2007;17:422-7.
104. Jung, SN; Yang, WK; Kim, J; Kim, HS; Kim, EJ; Yun, H; Park, H; Kim, SS; Choe, W; Kang, I; Ha, J. Reactive oxygen species stabilize hypoxia-inducible factor-1 alpha protein and stimulate transcriptional activity via AMP-activated protein kinase in DU145 human prostate cancer cells. Carcinogenesis. 2008;29:71321.
105. Hong, SP; Carlson, M. Regulation of snf1 protein kinase in response to environmental stress. J. Biol. Chem. 2007;282:16838-45.
106. Loos, B; Engelbrecht, AM. Cell death: a dynamic response concept. Autophagy. 2009;5:590-603.
107. Lanir, A; Clouse, ME; Lee, RG. Liver preservation for transplant. Evaluation of hepatic energy metabolism by 31P NMR. Transplantation. 1987;43:786-90.
108. Shimizu, S; Kanaseki, T; Mizushima, N; Mizuta, T; Arakawa-Kobayashi, S; Thompson, CB; Tsujimoto, Y. Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat. Cell Biol. 2004;6:1221-8.
109. Klionsky, DJ; Cregg, JM; Dunn, WA; Emr, SD; Sakai, Y; Sandoval, IV; Sibirny, A; Subramani, S; Thumm, M; Veenhuis, M; Ohsum, i Y. A unified nomenclature for yeast autophagy-related genes. Dev. Cell. 2003;5:539-45.
110. Pyo, JO; Jang, MH; Kwon, YK; Lee, HJ; Jun, JI; Woo, HN; Cho, DH; Choi, B; Lee, H; Kim, JH; Mizushima, N; Oshumi, Y; Jung, YK. Essential roles of Atg5 and FADD in autophagic cell death: dissection of autophagic cell death into vacuole formation and cell death. J. Biol. Chem. 2005;280:20722-9.
111. Yousefi, S; Perozzo, R; Schmid, I; Ziemiecki, A; Schaffner, T; Scapozza, L; Brunner, T; Simon, HU. Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis. Nat. Cell Biol. 2006;8:1124-32.
112. Du, C; Fang, M; Li, Y; Li, L; Wang, X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell. 2000;102:33-42.
113. Kim, JS; Qian, T; Lemasters, JJ. Mitochondrial permeability transition in the switch from necrotic to apoptotic cell death in ischemic rat hepatocytes. Gastroenterology. 2003;124:494-503.
114. Charlotte, F; L'Herminé, A; Martin, N; Geleyn, Y; Nollet, M; Gaulard, P; Zafrani, ES. Immunohistochemical detection of bcl-2 protein in normal and pathological human liver. Am. J. Pathol. 1994;144:460-5.
115. Shimizu, S ; Kanaseki, T ; Mizushima, N ; Mizuta, T; Arakawa-Kobayashi, S ; Thompson, CBT; Sujimoto, Y. Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat. Cell Biol. 2004;6:1221-8.
116. Bereiter-Hahn, J; Voth, M. Dynamics of mitochondria in living cells: shape changes, dislocations, fusion, and fission of mitochondria. Microsc. Res. Techn. 1994;27:198-219.
117. Nicholls, DG. Mitochondrial function and dysfunction in the cell: its relevance to aging and aging-related disease. Int. J. Biochem. Cell Biol. 2002;34:1372-1381.
118. Zanzami, N; Marchetti, P; Castedo, M; Zanin, C; Vayssiere, JL; Petit, PX; Kroemer, G.B. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J. Exp. Med. 1995;181:1661-1672.
119. Parone, PA; Da Cruz, S; Tondera, D; Mattenberger, Y; James, DI; Maechler, P; Barja, F; Martinou, JC. Preventing mitochondrial fission impairs mitochondrial function and leads to loss of mitochondrial DNA. PLoS ONE. 2008;3:e3257.
120. Scorrano, L; Ashiya, M; Buttle, K; Weller, S; Oakes, SA; Mannella, CA; Korsmeyer, SJ. A distinct pathway remodels mitochondrial cristae and mobilizes cytochrome c during apoptosis. Dev. Cell. 2002;2:55-67.
121. Suen, DF; Norris, KL; Youle, RJ. Mitochondrial dynamics and apoptosis. Genes Dev. 2008;22:1577-1590.
122. Frank, S; Gaume, B; Bergmann-Leitner, ES; Leitner, WW; Robert, EG; Catez F; Smith, CL; Youle, RJ. The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis. Dev Cell. 2001;1:515-525.
123. Bossy-Wetzel, E; Barsoum, MJ; Godzik, A; Schwarzenbacher, R; Lipton, SA. Mitochondrial fission in apoptosis, neurodegenerating and aging. Curr. Opin. Cell Biol. 2003;15:706-716]
124. Nakamura, N; Kimura, Y; Tokuda, M; Honda, S; Hirose, S. MARCH-V is a novel mitofusin 2-and Drp1-binding protein able to change mitochondrial morphology. EMBO Rep. 2006;7:1019-1022.
125. Cursio, R; Filippa, N; Miele, C; Colosetti, P; Auberger, P; Van Obberghen, E; Gugenheim, J. Fas ligand expression following normothermic liver ischemia-reperfusion.
126. Ciarlo, L; Manganelli, T; Garofalo, T; Matarrese, P; Tinari, A; Misasi, R; Malorni, W; Sorice, M. Association of fission proteins with mitochondrial raft-like domains. Cell Death Differ. 2010;17:1047-1058.
127. Brooks, C; Wei, Q; Feng, L; Dong, G; Tao, Y; Mei, L; Xie, ZJ; Dong, Z. Bak regulates mitochondrial morphology and pathology during apoptosis by interacting with mitofusins. Proc. Natl. Acad. Sci. U.S.A. 2007;104:11649-11654.
128. Hailey, DW; Rambold, AS; Satpute-Krishnan, P; Mitra, K; Sougrat, R; Kim, PK; lippincott-Schwartz, J. Mitochondria supply membranes for autophagosome biogenesis during starvation. Cell. 2010;141:656-667.
129. Gomes, LC; Di Benedetto, G; Scorrano, L. During autophagy mitochondria elongate, are spared from degradation and sustain cell viability. Nat. Cell Biol. 2011;13:589-598.
130. Gomes, LC; Scorrano, L. High levels of Fis1, a pro-fission mitochondrial protein, trigger autophagy. Biochim. Biophys. Acta. 2008;1777:860-866.
131. Tondera, D; grandemange, S; Jourdain, A; Karbowsky, M; Mattenberger, Y; Herzig, S; Da Cruz, S; Clerc, P; Raschke, I; Merkwirth, C; Ehses, S; Krause, F; Chan, DC; Alexander, C; Bauer, C; Youle, R; Langer, T; Martinou, JC. SLP-2 is required for stress-induced mitochondrial hyperfusion. EMBO J. 2009;28:1589-1600.
132. Okaya, T; Blanchard, J; Schuster, R; Kuboki, S; Husted, T; Caldwell, CC; Zingarelli, B; Wong, H; Solomkin, JS; Lentsch, AB. Age-dependent responses to hepatic ischemia/reperfusion injury. Shock. 2005;24:421-7.
133. Green, S. PPAR: a mediator of peroxisome proliferator action. Mutat. Res. 1995;333:101-9.
134. Akahori, T; Sho, M; Hamada, K; Suzaki, Y; Kuzumoto, Y; Nomi, T; Nakamura, S; Enomoto, K; Kanehiro, H; Nakajima, Y. Importance of peroxisome proliferator-activated receptor-gamma in hepatic ischemia/reperfusion injury in mice. J. Hepatol. 2007;47:784-92.
135. Kuboki, S; Shin, T; Huber, N; Eismann, T; Galloway, E; Schuster, R; Blanchard, J; Zingarelli, B; Lentsch, AB. Peroxisome proliferator-activated receptor-gamma protects against hepatic ischemia/reperfusion injury in mice. Hepatology. 2008;47:215-24.
136. Defamie, V; Cursio, R; Lebrigand, K; Moreilhon, C; Saint-Paul, M-C; Laurens, M; Crenesse, D; Cardinaud, B; Auberger, P; Gugenheim, J; Barbry, P; Mari, B. Gene expression profiling of human liver transplants identifies an early transcriptional signature associated with initial poor graft function. Am. J. Transpl. 2008;8:1221-1236.
137. Cursio, R; Colosetti, P; Auberger, P; Gugenheim, J. Liver apoptosis following normothermic ischemia-reperfusion: in vivo evaluation of caspase activity by FLIVO assay in rats. Transplant. Proc. 2008;40:2038-2041.
138. Yu, L; Lenardo, MJ; Baehrecke, EH. Autophagy and caspases: a new cell death program. Cell Cycle. 2004;3:1124-6.
139. Karantza-Wadsworth, V; Patel, S; Kravchuk, O; Chen, G; Mathew, R; jin, S; White, E. Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. Genes Dev. 2007;21:1621-35.
140. Kroemer, G; Galluzzi, L; Vandenabeele, P; Abrams, J; Alnemri, ES; Baehrecke, EH; Blagosklonny, MV; El-Deiry, WS; Golstein, P; Green, DR; Hengartner, M; Knight, RA; Kumar, S; Lipton, SA; Malorni, W; Nuňez, G; Peter, ME; Tschopp, J; Yuan, J; Piacentini, M; Zhivotovsky, B; Melino, G; Nomenclature Committee on Cell Death 2009. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ. 2009;16:3-11.
141. Maruyama, R; Goto, K; Takemura, G; Ono, K; Nagao, K; Horie, T; Tsujimoto, A; Kanamori, H; Miyata, S; Ushikoshi, H; Nagashima, K; Minatoguchi, S; Fujiwara, T; Fujiwara, H. Morphological and biochemical characterization of basal and starvation-induced autophagy in isolated adult rat cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol. 2008;295:H1599-607.
142. Samara, C; Syntichaki, P; Tavernarakis, N. Autophagy is required for necrotic cell death in Caenorhabditis elegans. Cell Death Differ. 2008;15:105-12.
143. Artal-Sanz, M; Tavernarakis, N. Proteolytic mechanisms in necrotic cell death and neurodegeneration. FEBSLett. 2005;579:3287-96.
144. Sybers, HD; Ingwall, J; DeLuca, M. Autophagy in cardiac myocytes. Recent Adv. Stud. Cardiac. Struct. Metab. 1976;12:453-63.
145. Huet, PM; Nagaoka, MR; Desbiens, G; Tarrab, E; Brault, A; Bralet, MP; Bilodeau, M. Sinusoidal endothelial cell and hepatocyte death following cold ischemia-warm reperfusion of the rat liver. Hepatology. 2004;39:1110-9.
146. Lemasters, JJ; Nieminen, AL; Qian, T; Trost, LC; Elmore, SP; Nishimura, Y; Crowe, RA; Cascio, WE; Bradham, CA; Brenner, DA; Herman, B. The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim. Biophys. Acta. 1998;1366:177-96.
147. Ferri, KF; Kroemer, G. Organelle-specific initiation of cell death pathways. Nat. Cell Biol. 2001;3: E255-63.
148. Gump, JM; Thorburn, A. Autophagy and apoptosis: what is the connection? Trends Cell Biol. 2011;21:387-92. May 9.
149. Kaminskyy, V; Zhivotovsky, B. Proteases in autophagy. Biochim. Biophys. Acta. 2011 May 24. [Epub ahead of print]
150. Saftig, P; Chapter 3 Physiology of the lysosome, Fabry Disease: Perspectives from 5 Years of FOS, Mehta A, Beck M, Sunder-Plassmann G, editors, Oxford: Oxford PharmaGenesis; 2006.
151. Takahashi, K ; Ueno, T ; Tanida, I ; Minematsu-Ikeguchi, N ; Murata, M ; Kominami, E. Characterization of CAA0225, a novel inhibitor specific for cathepsin L, as a probe for autophagic proteolysis, Biol. Pharm. Bull. 2009;32:475-9.
152. Yang, M; Zhang, Y; Pan, J; Sun, J; Liu, J; Libby, P, Sukhova, GK; Doria, A; Katunuma, N; Peroni, OD; Guerre-Millo, M; Kahan, BB; Clement, K; Shi, GP. Cathepsin L activity controls adipogenesis and glucose tolerance. Nat. Cell Biol. 2007;9:970-7.
153. Hanada, K; Tamai, M; Yamagishi, M; Ohmura, S; Sawada, J; Tanaka, I. Isolation and characterization of E-64, a new thiol protease inhibitor. Agric. Biol. Chem. 1978;42:523-8.
154. Schotte, P ; Van Criekinge, W ; Van de Craen, M ; Van Loo, G ; Desmedt, M ; Grooten, J ; Cornelissen, M ; De Ridder, L ; Vandekerckhove, J ; Fiers, W ; Vandenabeele, P ; Beyaert, R. Cathepsin B-mediated activation of the proinflammatory caspase-11, Biochem. Biophys. Res. Commun. 1998;251:379-87.
155. Zhou, Q; Salvesen, GS. Activation of pro-caspase-7 by serine proteases includes a non-canonical specificity. Biochem. J. 1997;324:361-4.
156. Vancompernolle, K ; Van Herreweghe, F ; Pynaert, G ; Van de Craen, M ; De Vos, K ; Totty, N ; Sterling, A ; Fiers, W; Vandenabeele, P; Grooten, J. Atractyloside-induced release of cathepsin B, a protease with caspase-processing activity. FEBS Lett. 1998;438:150-8.
157. Jones, B; Roberts, PJ; Faubion, WA; Kominami, E; Gores, GJ. Cystatin A expression reduces bile salt-induced apoptosis in a rat hepatoma cell line. Am. J. Physiol. 1998;275:G723-30.
158. Baskin, ES ; Canbay, A ; Bronk, SF ; Werneburg, N; Guicciardi, ME; Nyberg, SL; Gores, GJ. Cathepsin B inactivation attenuates hepatocyte apoptosis and liver damage in steatotic livers after cold ischemia-warm reperfusion injury. Am. J. Physiol. Gastrointest. Liver Physiol. 2005;288:G396-G402.
159. Guicciardi, ME; Leist, M; Gores, GJ. Lysosomes in cell death. Oncogene. 2004;23:2881-90.
160. Prestwick Chemical Library. www.prestwickchemical.com
161. Clinical trials. www.clinicaltrials.gov
162. Orii, R; Sugawara, Y; Hayashida, M; Yamada, Y; Chang, K; Takayama, T; et al. Effects of amrinone on ischaemia-reperfuison injury in cirrhotic patients undergoing hepatectomy: a comparative study with prostaglandin E1. Br. J. Anaesth. 2000;85:389-395.
163. Cecconi, F. Peptides and peptidomimetics: their relevance in autophagy, Gastroenterol. Hepatol. 2009;2:S27-33.
164. Kanki, S; Jaalouk, DE; Lee, S; Yu, AYC; Gannon, J; Lee, RT. Identification of targeting peptides for ischemic myocardium by in vivo phage display. J. Mol. Cell Cardiology. 2011;50:841-8.
165. Hundeshagen, P; Hamacher-Brady, A; Eils, R; Brady, NR. Concurrent detection of autolysosome formation and lysosomal degradation by flow cytometry in a highcontent screen for inducers of autophagy. BMC Biol. 2011 ;9:38.
166. Buss, SJ; Muenz, S; Riffel, JH; Malekar, P; Hagenmueller, M; Weiss, CS; Bea, F; Bekeredjian, R; Schinke-Braun, M; Izumo, S; Katus, HA; Hardt, SE. Beneficial effects of Mammalian target of rapmycin inhibition on left ventricular remodelling after myocardial infarction. J. Am. Coll Cardiol. 2009;54:2435-46.
167. Baur, JA; Sinclair, DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov. 2006;5:493-506]
168. Easton, JB; Houghton PJ. mTOR and cancer therapy. Oncogene. 2006;25:6436-46.].
169. Wu, Y-T; Tan, HL; Shui, G; Bauvy, C; Huang, Q; Wenk, MR; Ong, C-N; Codogno, P, Shen, H-M. Dual role of 3-methylanine in modulation of autophagy via different temporal patterns of inhibition on class I and class III phosphoinositide 3-kinase. J. Biol. Chem. 2010;285:10850-61.
170. Selzner, N; Rudiger, H; Graf, R; Clavien, PA. Protectives strategies against ischemic injury of the liver. Gastroenterology. 2003;125:17-36.
171. Bahde, R; Spiegel, HU. Hepatic ischaemia-reperfusion injury from bench to bedside. Br. J. Surg. 2010;97:1461-75.
172. Abu-Amara, M; Gurusamy, K; Hori, S; Glantzounis, G; Fuller, B; Davidson, B. Systematic review of randomized controlled trials of pharmacological interventions to reduce ischaemia-reperfusion injury in elective liver resection with vascular occlusion. HPB. 2010;12:4-14.
173. Murry, CE; Jennings, RB; Reimer, KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124-36.
174. Gurusamy, KS; Gonzalez, HD; Davidson, BR. Current protective strategies in liver surgery. World J. Gastroenterol. 2010;16:6098-103.
175. Gurusamy, KS; Kumar, Y; Sharma, D; Davidson, BR. Ischaemic preconditioning for liver transplantation. Cochrane Database Syst. Rev. 2008 Jan 23;(1):CD006315.
176. Tapuria, N; Kumar, Y; Habib, MM; Abu Amara, M; Seifalian, AM; Davidson, BR. Remote ischemic preconditioning: a novel protective method from ischemia reperfusion injury--a review. J. Surg. Res. 2008;150:304-30.
177. Hausenloy, DJ; Yellon, DM. Remote ischaemic preconditioning: underlying mechanisms and clinical application. Cardiovasc. Res. 2008;79:377-86.
178. Koti, RS; Seifalian, AM; Davidson, BR. Protection of the liver by ischemic preconditioning: a review of mechanisms and clinical applications. Dig. Surg. 2003;20:383-96.
179. Barrier, A; Olaya, N; Chiappini, F; Roser, F; Scatton, O; Artus, C; Franc, B; Dudoit, S; Flahault, A; Debuire, B; Azoulay, D; Lemoine, A. Ischemic preconditioning modulates the expression of several genes, leading to the overproduction of IL-1Ra, iNOS, and Bcl-2 in a human model of liver ischemia-reperfusion. FASEB J. 2005;19:1617-26.
180. Yamabe, K; Shimizu, S; Kamiike, W; Waguri, S; Eguchi, Y; Hasegawa, J; Okuno, S; Yoshioka, Y; Ito, T; Sawa, Y; Uchiyama, Y; Tsujimoto, Y; Matsuda, H. Prevention of hypoxic liver cell necrosis by in vivo human bcl-2 gene transfection. Biochem. Biophys. Res. Commun. 1998;243:217-23.
181. Fazi, B; Bursch, W; Fimia, GM; Nardacci, R; Piacentini, M; Di Sano, F; Piredda, L. Fenretinide induces autophagic cell death in caspase-defective breast cancer cells. Autophagy. 2008;4:435-41.
182. Azoulay, D; Del Gaudio, M; Andreani, P; Ichai, P; Sebag, M; Adam, R; Scatton, O; Min, BY; Delvard, V; Lemoine, A; Bismuth, H; Castaing, D. Effects of 10 minutes of ischemic preconditioning of the cadaveric liver on the graft's preservation and function: the ying and the yang. Ann. Surg. 2005;242:133-9.
183. Stegemann, J; Hirner, A; Rauen, U; Minor, T. Gaseous oxygen persufflation or oxygenated machine perfusion with Custodiol-N for long-term preservation of ischemic rat livers? Cryobiology. 2009;58:45-51.
184. Minor, T; Lüer, B; Efferz, P. Dopamine improves hypothermic machine preservation of the liver. Cryobiology. 2011 May 30. [Epub ahead of print]
185. Koetting, M; Lüer, B; Efferz, P; Paul, A; Minor, T. Optimal time for hypothermic reconditioning of liver grafts by venous systemic oxygen persufflation in a large animal model. Transplantation. 2011;91:42-7.
186. Fuller, BJ; Busza, AL; Proctor, E. Possible resuscitation of liver function by hypothermic reperfusion in vitro after prolonged (24-hour) cold preservation--a 31P NMR study. Transplantation. 1990;50:511-3.
187. Vajdová, K; Graf, R; Clavien, PA. ATP-supplies in the cold-preserved liver: A long-neglected factor of organ viability. Hepatology. 2002;36:1543-52.
188. Leducq, N; Delmas-Beauvieux, MC; Bourdel-Marchasson, I; Dufour, S; Gallis, JL; Canioni, P; Diolez, P. Mitochondrial permeability transition during hypothermic to normothermic reperfusion in rat liver demonstrated by the protective effect of cyclosporin A. Biochem. J. 1998;336:501-6.
189. Delmas-Beauvieux, MC; Gallis, JL; Clerc, M; Canioni, P. 31P NMR studies of rat liver cold preservation with histidine-buffered lactobionate solution. Cryobiology. 1993;30:551-61.
190. Holloway, CM; Harvey, PR; Strasberg, SM. Viability of sinusoidal lining cells in cold-preserved rat liver allografts. Transplantation. 1990;49:225-9.
191. Sindram, D; Porte, RJ; Hoffman, MR; Bentley, RC; Clavien, PA. Synergism between platelets and leukocytes in inducing endothelial cell apoptosis in the cold ischemic rat liver: a Kupffer cell-mediated injury. FASEB J. 2001;15:1230-2.
192. Lelli, JL; Becks, LL; Dabrowska, MI; Hinshaw, DB. ATP converts necrosis to apoptosis in oxidant-injured endothelial cells. Free Radic. Biol. Med. 1998;25:694-702.
193. Leist, M; Single, B; Castoldi, AF; Kühnle, S; Nicotera, P. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J. Exp. Med. 1997;185:1481-6.
194. Mortimore, GE; Schworer, CM. Induction of autophagy by amino-acid deprivation in perfused rat liver. Nature. 1977;270:174-6.
195. Cywes, R; Greig, PD; Sanabria, JR; Clavien, PA; Levy, GA; Harvey, PR; Strasberg, SM. Effect of intraportal glucose infusion on hepatic glycogen content and degradation, and outcome of liver transplantation. Ann. Surg. 1992;216:235-46.
196. Xia, X; Kar, R; Gluhak-Heinrich, J; Yao, W; Lane, NE; Bonewald, LF; Biswas, SK; Lo, WK; Jiang, JX. Glucocorticoid-induced autophagy in osteocytes. J. Bone Miner. Res. 2010;25:2479-88.
197. Ezaki, J; Matsumoto, N; Takeda-Ezaki, M; Komatsu, M; Takahashi, K; Hiraoka, Y; Taka, H; Fujimura, T; Takehana, K; Yoshida, M; Iwata, J; Tanida, I; Furuya, N; Zheng, D; Tada, N; Tanaka, K; Kominami, E; Ueno, T. Liver autophagy contributes to the maintenance of blood glucose and amino acid levels. Autophagy. 2011;7:727-36.
198. Li, XL; Man, K; Ng, KT; Lee, TK; Lo, CM; Fan, ST. Insulin in UW solution exacerbates hepatic ischemia/reperfusion injury by energy depletion through the IRS-2/SREBP-1c pathway. Liver Transpl. 2004;10:1173-82.